Shares of Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Free Report) traded down 1.1% during mid-day trading on Friday . The stock traded as low as $0.91 and last traded at $0.91. 795 shares traded hands during trading, a decline of 95% from the average session volume of 17,504 shares. The stock had previously closed at $0.92.
Fresh Tracks Therapeutics Price Performance
The stock has a 50-day moving average price of $0.91 and a 200 day moving average price of $0.91.
Fresh Tracks Therapeutics (NASDAQ:FRTX – Get Free Report) last announced its quarterly earnings data on Friday, March 15th. The company reported ($0.20) earnings per share for the quarter. Fresh Tracks Therapeutics had a negative return on equity of 60.83% and a negative net margin of 91.29%.
About Fresh Tracks Therapeutics
Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.
Read More
- Five stocks we like better than Fresh Tracks Therapeutics
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 4/22 – 4/26
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Stocks Leading the U.S. Agriculture Comeback
- ESG Stocks, What Investors Should Know
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
